Rank | Gene Set | Z-score |
---|---|---|
1 | urate metabolic process (GO:0046415) | 5.70845126 |
2 | drug transmembrane transport (GO:0006855) | 4.73146679 |
3 | drug transport (GO:0015893) | 4.64890505 |
4 | NADH metabolic process (GO:0006734) | 4.64474746 |
5 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.40292375 |
6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.37824466 |
7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.37824466 |
8 | modulation by symbiont of host immune response (GO:0052553) | 4.37824466 |
9 | positive regulation by symbiont of host defense response (GO:0052509) | 4.37824466 |
10 | modulation by symbiont of host defense response (GO:0052031) | 4.37824466 |
11 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.37824466 |
12 | aminoglycoside antibiotic metabolic process (GO:0030647) | 4.27449499 |
13 | epoxygenase P450 pathway (GO:0019373) | 4.25983579 |
14 | modified amino acid transport (GO:0072337) | 4.13136560 |
15 | glycosphingolipid catabolic process (GO:0046479) | 4.02315552 |
16 | interferon-gamma secretion (GO:0072643) | 3.84956254 |
17 | glycolipid catabolic process (GO:0019377) | 3.84258851 |
18 | cysteine metabolic process (GO:0006534) | 3.77110537 |
19 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.75072610 |
20 | organic cation transport (GO:0015695) | 3.67699639 |
21 | toxin transport (GO:1901998) | 3.66137838 |
22 | peptide catabolic process (GO:0043171) | 3.63989845 |
23 | drug catabolic process (GO:0042737) | 3.61637970 |
24 | neutrophil activation involved in immune response (GO:0002283) | 3.61067085 |
25 | oligosaccharide catabolic process (GO:0009313) | 3.59851682 |
26 | macrophage activation involved in immune response (GO:0002281) | 3.54562906 |
27 | respiratory burst (GO:0045730) | 3.49474937 |
28 | folic acid transport (GO:0015884) | 3.45435834 |
29 | phosphate ion transport (GO:0006817) | 3.44201498 |
30 | urea cycle (GO:0000050) | 3.43816977 |
31 | urea metabolic process (GO:0019627) | 3.43787253 |
32 | angiotensin maturation (GO:0002003) | 3.43466040 |
33 | positive regulation of interferon-alpha production (GO:0032727) | 3.43326215 |
34 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.43030562 |
35 | vitamin D metabolic process (GO:0042359) | 3.41510963 |
36 | glycoside metabolic process (GO:0016137) | 3.39564590 |
37 | low-density lipoprotein particle clearance (GO:0034383) | 3.38612087 |
38 | ceramide catabolic process (GO:0046514) | 3.37960750 |
39 | response to thyroid hormone (GO:0097066) | 3.36813896 |
40 | exogenous drug catabolic process (GO:0042738) | 3.30754018 |
41 | adhesion of symbiont to host (GO:0044406) | 3.29393821 |
42 | regulation of antigen processing and presentation (GO:0002577) | 3.28895974 |
43 | ethanol oxidation (GO:0006069) | 3.28702481 |
44 | lysine catabolic process (GO:0006554) | 3.28611244 |
45 | lysine metabolic process (GO:0006553) | 3.28611244 |
46 | regulation of cellular extravasation (GO:0002691) | 3.26339497 |
47 | regulation of interferon-alpha production (GO:0032647) | 3.21677015 |
48 | nitrogen cycle metabolic process (GO:0071941) | 3.19867827 |
49 | immunoglobulin mediated immune response (GO:0016064) | 3.16051749 |
50 | regulation of cholesterol storage (GO:0010885) | 3.15040444 |
51 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.14300420 |
52 | fructose metabolic process (GO:0006000) | 3.13388137 |
53 | sphingolipid catabolic process (GO:0030149) | 3.11804697 |
54 | folic acid metabolic process (GO:0046655) | 3.09197191 |
55 | tricarboxylic acid metabolic process (GO:0072350) | 3.05891504 |
56 | membrane lipid catabolic process (GO:0046466) | 3.05102514 |
57 | phosphate ion transmembrane transport (GO:0035435) | 3.04792099 |
58 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.03779164 |
59 | ethanol metabolic process (GO:0006067) | 3.03405836 |
60 | cellular response to type I interferon (GO:0071357) | 3.02346180 |
61 | type I interferon signaling pathway (GO:0060337) | 3.02346180 |
62 | response to type I interferon (GO:0034340) | 3.00519321 |
63 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.99419547 |
64 | vitamin transport (GO:0051180) | 2.98415537 |
65 | pinocytosis (GO:0006907) | 2.97666877 |
66 | intestinal absorption (GO:0050892) | 2.96560971 |
67 | uronic acid metabolic process (GO:0006063) | 2.96504922 |
68 | glucuronate metabolic process (GO:0019585) | 2.96504922 |
69 | regulation of vitamin metabolic process (GO:0030656) | 2.96334167 |
70 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.93440915 |
71 | pentose-phosphate shunt (GO:0006098) | 2.92609136 |
72 | proline biosynthetic process (GO:0006561) | 2.92182054 |
73 | NADPH regeneration (GO:0006740) | 2.92093229 |
74 | drug metabolic process (GO:0017144) | 2.91417391 |
75 | proline metabolic process (GO:0006560) | 2.91266192 |
76 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.90193072 |
77 | NIK/NF-kappaB signaling (GO:0038061) | 2.89106316 |
78 | alpha-linolenic acid metabolic process (GO:0036109) | 2.88912954 |
79 | phospholipid efflux (GO:0033700) | 2.88624914 |
80 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.87729528 |
81 | cellular glucuronidation (GO:0052695) | 2.87183268 |
82 | amino sugar catabolic process (GO:0046348) | 2.87158393 |
83 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.86518837 |
84 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.85054548 |
85 | response to peptidoglycan (GO:0032494) | 2.84380277 |
86 | response to host immune response (GO:0052572) | 2.83024036 |
87 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.83024036 |
88 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.83000212 |
89 | aldehyde catabolic process (GO:0046185) | 2.82203451 |
90 | glyoxylate metabolic process (GO:0046487) | 2.82146845 |
91 | complement activation, classical pathway (GO:0006958) | 2.81981620 |
92 | amyloid precursor protein catabolic process (GO:0042987) | 2.81057868 |
93 | regulation of cholesterol esterification (GO:0010872) | 2.77772647 |
94 | apoptotic cell clearance (GO:0043277) | 2.75121803 |
95 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.73602936 |
96 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.72982615 |
97 | primary alcohol catabolic process (GO:0034310) | 2.72268748 |
98 | vitamin transmembrane transport (GO:0035461) | 2.71038761 |
99 | excretion (GO:0007588) | 2.69123921 |
100 | quaternary ammonium group transport (GO:0015697) | 2.67938017 |
101 | phagosome maturation (GO:0090382) | 2.67790140 |
102 | basic amino acid transport (GO:0015802) | 2.66364612 |
103 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.66154431 |
104 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.65546134 |
105 | lipoprotein transport (GO:0042953) | 2.64010570 |
106 | plasma lipoprotein particle assembly (GO:0034377) | 2.63868112 |
107 | sexual reproduction (GO:0019953) | 2.61616658 |
108 | reactive oxygen species biosynthetic process (GO:1903409) | 2.60387817 |
109 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.59247070 |
110 | natural killer cell mediated immunity (GO:0002228) | 2.59247070 |
111 | amino-acid betaine metabolic process (GO:0006577) | 2.58928744 |
112 | renal absorption (GO:0070293) | 2.58813693 |
113 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.58499887 |
114 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.58499887 |
115 | detection of bacterium (GO:0016045) | 2.57807257 |
116 | positive regulation of interferon-beta production (GO:0032728) | 2.57322471 |
117 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.57140650 |
118 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.57140650 |
119 | phosphate ion homeostasis (GO:0055062) | 2.56379255 |
120 | trivalent inorganic anion homeostasis (GO:0072506) | 2.56379255 |
121 | N-acetylneuraminate metabolic process (GO:0006054) | 2.55893619 |
122 | glycosylceramide metabolic process (GO:0006677) | 2.55839582 |
123 | response to growth hormone (GO:0060416) | 2.55700600 |
124 | L-ascorbic acid metabolic process (GO:0019852) | 2.55461157 |
125 | regulation of guanylate cyclase activity (GO:0031282) | 2.54656973 |
126 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.54522036 |
127 | regulation of podosome assembly (GO:0071801) | 2.54366978 |
128 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.54233277 |
129 | homocysteine metabolic process (GO:0050667) | 2.53796594 |
130 | hormone catabolic process (GO:0042447) | 2.53685020 |
131 | detection of other organism (GO:0098543) | 2.52727701 |
132 | serine family amino acid metabolic process (GO:0009069) | 2.52039154 |
133 | leukotriene metabolic process (GO:0006691) | 2.51986591 |
134 | regulation of early endosome to late endosome transport (GO:2000641) | 2.51986351 |
135 | oxaloacetate metabolic process (GO:0006107) | 2.50915030 |
136 | positive regulation of type 2 immune response (GO:0002830) | 2.50167664 |
137 | positive regulation of antigen processing and presentation (GO:0002579) | 2.50075890 |
138 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.49580085 |
139 | response to host (GO:0075136) | 2.49580085 |
140 | response to host defenses (GO:0052200) | 2.49580085 |
141 | protein-lipid complex assembly (GO:0065005) | 2.49459571 |
142 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.48476274 |
143 | complement activation (GO:0006956) | 2.47717021 |
144 | regulation of mononuclear cell migration (GO:0071675) | 2.47509939 |
145 | T-helper 1 type immune response (GO:0042088) | 2.46953749 |
146 | regulation of apoptotic cell clearance (GO:2000425) | 2.46018634 |
147 | B cell mediated immunity (GO:0019724) | 2.46008779 |
148 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.45791931 |
149 | cellular response to interferon-gamma (GO:0071346) | 2.45658409 |
150 | wound healing, spreading of epidermal cells (GO:0035313) | 2.44812460 |
151 | hydrogen peroxide catabolic process (GO:0042744) | 2.44463472 |
152 | superoxide anion generation (GO:0042554) | 2.44373551 |
153 | NADP metabolic process (GO:0006739) | 2.44184075 |
154 | regulation of bile acid biosynthetic process (GO:0070857) | 2.44106095 |
155 | myeloid cell homeostasis (GO:0002262) | 2.43396480 |
156 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.43309275 |
157 | glucose 6-phosphate metabolic process (GO:0051156) | 2.41083135 |
158 | transcytosis (GO:0045056) | 2.40987095 |
159 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.40986212 |
160 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.40799707 |
161 | granulocyte activation (GO:0036230) | 2.40512312 |
162 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.39777281 |
163 | cyclooxygenase pathway (GO:0019371) | 2.39168077 |
164 | cytokine secretion (GO:0050663) | 2.38804194 |
165 | lipoprotein metabolic process (GO:0042157) | 2.38754204 |
166 | adhesion of symbiont to host cell (GO:0044650) | 2.38628515 |
167 | virion attachment to host cell (GO:0019062) | 2.38628515 |
168 | positive regulation of leukocyte degranulation (GO:0043302) | 2.37530419 |
169 | protein localization to endosome (GO:0036010) | 2.37477276 |
170 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.37095308 |
171 | response to interferon-gamma (GO:0034341) | 2.36617091 |
172 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.34905728 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.18248241 |
2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.59669485 |
3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.69783970 |
4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.63906351 |
5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.61802809 |
6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.61192639 |
7 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.46293932 |
8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.36479973 |
9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.35369575 |
10 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.29645665 |
11 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.29581015 |
12 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.29454512 |
13 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.17600146 |
14 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.16944909 |
15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.12528887 |
16 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.09101289 |
17 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.05947025 |
18 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.96624321 |
19 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.92869114 |
20 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.87817573 |
21 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.86955356 |
22 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.84250486 |
23 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.81232276 |
24 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.76846375 |
25 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.72544876 |
26 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.64581235 |
27 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.62605421 |
28 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.60692899 |
29 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.59044431 |
30 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.56961896 |
31 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.56480220 |
32 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.55660118 |
33 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.53063679 |
34 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.52639227 |
35 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.52054019 |
36 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.51640042 |
37 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.50643941 |
38 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.49235716 |
39 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.44535646 |
40 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.40395091 |
41 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.39802071 |
42 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.39166955 |
43 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.37115337 |
44 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.32861358 |
45 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.32760261 |
46 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.32339196 |
47 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.31471704 |
48 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.31333918 |
49 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.30780873 |
50 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.30009658 |
51 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.28189604 |
52 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.27404176 |
53 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.26651336 |
54 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.26175326 |
55 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.23940981 |
56 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.22862837 |
57 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.21924866 |
58 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.21794934 |
59 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20058176 |
60 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.19120950 |
61 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.19106757 |
62 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.19041198 |
63 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.18498145 |
64 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.17987592 |
65 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.17882471 |
66 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.17815049 |
67 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.17426683 |
68 | SA1_27219007_Chip-Seq_Bcells_Human | 1.16413123 |
69 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.14563406 |
70 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.14321142 |
71 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.14160737 |
72 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13269053 |
73 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.12635899 |
74 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12290071 |
75 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.12157725 |
76 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.12080016 |
77 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.11999923 |
78 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.11675034 |
79 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.11524756 |
80 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10472596 |
81 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.09977959 |
82 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.09939981 |
83 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.09348308 |
84 | * MAF_26560356_Chip-Seq_TH1_Human | 1.09040766 |
85 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.08854152 |
86 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.08760768 |
87 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.08451827 |
88 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08030792 |
89 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.06805285 |
90 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.05872279 |
91 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.05845807 |
92 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05579725 |
93 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04715186 |
94 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.04251703 |
95 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04202839 |
96 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.03266540 |
97 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03178149 |
98 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.03131371 |
99 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.02743883 |
100 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.02065939 |
101 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.01131421 |
102 | P68_20966046_ChIP-Seq_HELA_Human | 1.00786540 |
103 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.00743019 |
104 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.00302739 |
105 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.99420667 |
106 | GATA1_19941826_ChIP-Seq_K562_Human | 0.99198958 |
107 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.99035188 |
108 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98777040 |
109 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.98271180 |
110 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97973969 |
111 | SPI1_23127762_ChIP-Seq_K562_Human | 0.96401874 |
112 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.95805993 |
113 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95773118 |
114 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.95473768 |
115 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.95339627 |
116 | MYB_26560356_Chip-Seq_TH2_Human | 0.94799408 |
117 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.94556148 |
118 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.94338675 |
119 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.94260476 |
120 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.93375447 |
121 | UTX_26944678_Chip-Seq_JUKART_Human | 0.93148740 |
122 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.92900571 |
123 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.92559812 |
124 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.91729492 |
125 | MYC_22102868_ChIP-Seq_BL_Human | 0.91527912 |
126 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.90923216 |
127 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.90781550 |
128 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.90590777 |
129 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.89870662 |
130 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.89790545 |
131 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.89727846 |
132 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.89468706 |
133 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.89178689 |
134 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.88192004 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005058_abnormal_lysosome_morphology | 4.31906014 |
2 | MP0005360_urolithiasis | 4.26564326 |
3 | MP0009840_abnormal_foam_cell | 3.82168163 |
4 | MP0004019_abnormal_vitamin_homeostasis | 3.07559841 |
5 | MP0003436_decreased_susceptibility_to | 2.64567114 |
6 | MP0006082_CNS_inflammation | 2.58366892 |
7 | MP0003191_abnormal_cellular_cholesterol | 2.53094055 |
8 | MP0002139_abnormal_hepatobiliary_system | 2.42372444 |
9 | MP0003172_abnormal_lysosome_physiology | 2.39463325 |
10 | MP0005332_abnormal_amino_acid | 2.32323007 |
11 | MP0009643_abnormal_urine_homeostasis | 2.32258517 |
12 | MP0001835_abnormal_antigen_presentation | 2.31324463 |
13 | MP0003303_peritoneal_inflammation | 2.13332803 |
14 | MP0002136_abnormal_kidney_physiology | 1.93511377 |
15 | MP0002419_abnormal_innate_immunity | 1.93129123 |
16 | MP0009785_altered_susceptibility_to | 1.89837478 |
17 | MP0002138_abnormal_hepatobiliary_system | 1.85520422 |
18 | MP0003195_calcinosis | 1.82879904 |
19 | MP0001756_abnormal_urination | 1.81592791 |
20 | MP0003186_abnormal_redox_activity | 1.74894424 |
21 | MP0002148_abnormal_hypersensitivity_rea | 1.74627557 |
22 | MP0003705_abnormal_hypodermis_morpholog | 1.73140038 |
23 | MP0000604_amyloidosis | 1.72762800 |
24 | MP0004043_abnormal_pH_regulation | 1.71039505 |
25 | MP0005000_abnormal_immune_tolerance | 1.70782882 |
26 | MP0003879_abnormal_hair_cell | 1.69844190 |
27 | MP0005025_abnormal_response_to | 1.68689671 |
28 | MP0001958_emphysema | 1.62588519 |
29 | MP0008875_abnormal_xenobiotic_pharmacok | 1.62049521 |
30 | MP0010352_gastrointestinal_tract_polyps | 1.55768891 |
31 | MP0004947_skin_inflammation | 1.51695873 |
32 | MP0003329_amyloid_beta_deposits | 1.49572159 |
33 | MP0001765_abnormal_ion_homeostasis | 1.48526087 |
34 | MP0001533_abnormal_skeleton_physiology | 1.48069335 |
35 | MP0003724_increased_susceptibility_to | 1.46321621 |
36 | MP0008469_abnormal_protein_level | 1.45896106 |
37 | MP0002452_abnormal_antigen_presenting | 1.45786490 |
38 | MP0010234_abnormal_vibrissa_follicle | 1.45047841 |
39 | MP0004858_abnormal_nervous_system | 1.44251876 |
40 | MP0003300_gastrointestinal_ulcer | 1.43671880 |
41 | MP0009333_abnormal_splenocyte_physiolog | 1.43292243 |
42 | MP0001845_abnormal_inflammatory_respons | 1.40946184 |
43 | MP0005636_abnormal_mineral_homeostasis | 1.40278220 |
44 | MP0001666_abnormal_nutrient_absorption | 1.39133126 |
45 | MP0005464_abnormal_platelet_physiology | 1.37884335 |
46 | MP0003448_altered_tumor_morphology | 1.37555387 |
47 | MP0003806_abnormal_nucleotide_metabolis | 1.35967504 |
48 | MP0009764_decreased_sensitivity_to | 1.32256831 |
49 | MP0003566_abnormal_cell_adhesion | 1.31208253 |
50 | MP0001790_abnormal_immune_system | 1.29933981 |
51 | MP0005387_immune_system_phenotype | 1.29933981 |
52 | MP0005377_hearing/vestibular/ear_phenot | 1.28533041 |
53 | MP0003878_abnormal_ear_physiology | 1.28533041 |
54 | MP0001881_abnormal_mammary_gland | 1.28494706 |
55 | MP0005451_abnormal_body_composition | 1.27450901 |
56 | MP0002723_abnormal_immune_serum | 1.26749406 |
57 | MP0002254_reproductive_system_inflammat | 1.23459529 |
58 | MP0000343_altered_response_to | 1.23108889 |
59 | MP0005319_abnormal_enzyme/_coenzyme | 1.22411292 |
60 | MP0010155_abnormal_intestine_physiology | 1.20283660 |
61 | MP0001819_abnormal_immune_cell | 1.15191892 |
62 | MP0000920_abnormal_myelination | 1.12961221 |
63 | MP0008260_abnormal_autophagy | 1.12388562 |
64 | MP0001800_abnormal_humoral_immune | 1.11660485 |
65 | MP0002420_abnormal_adaptive_immunity | 1.11432125 |
66 | MP0004264_abnormal_extraembryonic_tissu | 1.11134991 |
67 | MP0005166_decreased_susceptibility_to | 1.10297381 |
68 | MP0010307_abnormal_tumor_latency | 1.10291023 |
69 | MP0002166_altered_tumor_susceptibility | 1.09962580 |
70 | MP0002998_abnormal_bone_remodeling | 1.08952615 |
71 | MP0005310_abnormal_salivary_gland | 1.08639370 |
72 | MP0000685_abnormal_immune_system | 1.07912690 |
73 | MP0000609_abnormal_liver_physiology | 1.06888112 |
74 | MP0002405_respiratory_system_inflammati | 1.04875658 |
75 | MP0010329_abnormal_lipoprotein_level | 1.04289821 |
76 | MP0000858_altered_metastatic_potential | 1.04177628 |
77 | MP0004782_abnormal_surfactant_physiolog | 1.03746159 |
78 | MP0003868_abnormal_feces_composition | 1.03300078 |
79 | MP0003075_altered_response_to | 1.03128477 |
80 | MP0001853_heart_inflammation | 1.02598684 |
81 | MP0005085_abnormal_gallbladder_physiolo | 1.01355103 |
82 | MP0001873_stomach_inflammation | 0.98098475 |
83 | MP0003866_abnormal_defecation | 0.97222773 |
84 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.96511099 |
85 | MP0004147_increased_porphyrin_level | 0.96442780 |
86 | MP0003252_abnormal_bile_duct | 0.95763422 |
87 | MP0005167_abnormal_blood-brain_barrier | 0.94372887 |
88 | MP0005671_abnormal_response_to | 0.93693086 |
89 | MP0000490_abnormal_crypts_of | 0.92088954 |
90 | MP0001849_ear_inflammation | 0.91756149 |
91 | MP0003693_abnormal_embryo_hatching | 0.91712353 |
92 | MP0008004_abnormal_stomach_pH | 0.89748062 |
93 | MP0004510_myositis | 0.89582640 |
94 | MP0005365_abnormal_bile_salt | 0.89300447 |
95 | MP0002135_abnormal_kidney_morphology | 0.89218836 |
96 | MP0001663_abnormal_digestive_system | 0.87526348 |
97 | MP0000689_abnormal_spleen_morphology | 0.86993214 |
98 | MP0003690_abnormal_glial_cell | 0.85276758 |
99 | MP0000598_abnormal_liver_morphology | 0.84652369 |
100 | MP0002796_impaired_skin_barrier | 0.84164290 |
101 | MP0000716_abnormal_immune_system | 0.83220653 |
102 | MP0005023_abnormal_wound_healing | 0.82181403 |
103 | MP0009278_abnormal_bone_marrow | 0.81080375 |
104 | MP0003453_abnormal_keratinocyte_physiol | 0.81029857 |
105 | MP0003183_abnormal_peptide_metabolism | 0.80963306 |
106 | MP0001764_abnormal_homeostasis | 0.80939883 |
107 | MP0009379_abnormal_foot_pigmentation | 0.80415865 |
108 | MP0002722_abnormal_immune_system | 0.78534239 |
109 | MP0000678_abnormal_parathyroid_gland | 0.76611433 |
110 | MP0002429_abnormal_blood_cell | 0.76142362 |
111 | MP0000538_abnormal_urinary_bladder | 0.76087779 |
112 | MP0005409_darkened_coat_color | 0.74714487 |
113 | MP0000371_diluted_coat_color | 0.74568071 |
114 | MP0005165_increased_susceptibility_to | 0.74195304 |
115 | MP0002876_abnormal_thyroid_physiology | 0.73334247 |
116 | MP0009763_increased_sensitivity_to | 0.73106699 |
117 | MP0002118_abnormal_lipid_homeostasis | 0.72067390 |
118 | MP0003656_abnormal_erythrocyte_physiolo | 0.71638683 |
119 | MP0003795_abnormal_bone_structure | 0.70739372 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Vacuolated lymphocytes (HP:0001922) | 6.05978646 |
2 | Increased cerebral lipofuscin (HP:0011813) | 4.71263573 |
3 | Abnormality of macrophages (HP:0004311) | 4.52288511 |
4 | Gout (HP:0001997) | 4.08315287 |
5 | Systemic lupus erythematosus (HP:0002725) | 4.07800456 |
6 | Eczematoid dermatitis (HP:0000976) | 4.05227969 |
7 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.04852615 |
8 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.02598795 |
9 | Dysostosis multiplex (HP:0000943) | 3.86551863 |
10 | Recurrent abscess formation (HP:0002722) | 3.82571395 |
11 | Abnormality of glycolipid metabolism (HP:0010969) | 3.73836259 |
12 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.73836259 |
13 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.73836259 |
14 | Nasal polyposis (HP:0100582) | 3.73458700 |
15 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.69407900 |
16 | Abnormality of the nasal mucosa (HP:0000433) | 3.64603066 |
17 | Chronic otitis media (HP:0000389) | 3.62098939 |
18 | Proximal tubulopathy (HP:0000114) | 3.59376324 |
19 | Autoimmune thrombocytopenia (HP:0001973) | 3.59020412 |
20 | Axonal loss (HP:0003447) | 3.54285756 |
21 | Recurrent bacterial skin infections (HP:0005406) | 3.46708548 |
22 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.42198556 |
23 | Complement deficiency (HP:0004431) | 3.37885321 |
24 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.32270396 |
25 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.29306190 |
26 | Mucopolysacchariduria (HP:0008155) | 3.29306190 |
27 | Hyperglycinuria (HP:0003108) | 3.29250394 |
28 | Abnormality of purine metabolism (HP:0004352) | 3.25700710 |
29 | Metabolic alkalosis (HP:0200114) | 3.24887662 |
30 | Abnormality of chloride homeostasis (HP:0011422) | 3.20740873 |
31 | Abnormality of proline metabolism (HP:0010907) | 3.12682704 |
32 | Hydroxyprolinuria (HP:0003080) | 3.12682704 |
33 | Hyperactive renin-angiotensin system (HP:0000841) | 3.12504792 |
34 | Hypokalemic alkalosis (HP:0001949) | 3.12419748 |
35 | Nausea (HP:0002018) | 3.09565681 |
36 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.02845312 |
37 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.02845312 |
38 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.02845312 |
39 | Increased circulating renin level (HP:0000848) | 3.00537588 |
40 | Abnormality of complement system (HP:0005339) | 2.95074471 |
41 | Hypomagnesemia (HP:0002917) | 2.85370523 |
42 | Pustule (HP:0200039) | 2.80711307 |
43 | Interstitial pulmonary disease (HP:0006530) | 2.76359694 |
44 | Polyuria (HP:0000103) | 2.75555746 |
45 | Abnormality of magnesium homeostasis (HP:0004921) | 2.75534177 |
46 | Abnormality of renal excretion (HP:0011036) | 2.75435874 |
47 | Abnormal urine output (HP:0012590) | 2.74491330 |
48 | Increased purine levels (HP:0004368) | 2.73833567 |
49 | Hyperuricemia (HP:0002149) | 2.73833567 |
50 | Fat malabsorption (HP:0002630) | 2.66497116 |
51 | Abnormality of nucleobase metabolism (HP:0010932) | 2.64130427 |
52 | Chronic diarrhea (HP:0002028) | 2.63226109 |
53 | Glomerulonephritis (HP:0000099) | 2.61226079 |
54 | Tetany (HP:0001281) | 2.58461626 |
55 | Neurofibrillary tangles (HP:0002185) | 2.52388199 |
56 | Abnormality of glycine metabolism (HP:0010895) | 2.52105781 |
57 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.52105781 |
58 | Generalized aminoaciduria (HP:0002909) | 2.49866648 |
59 | Abnormality of urine glucose concentration (HP:0011016) | 2.47403689 |
60 | Glycosuria (HP:0003076) | 2.47403689 |
61 | Intrahepatic cholestasis (HP:0001406) | 2.43863438 |
62 | Gingivitis (HP:0000230) | 2.43742979 |
63 | Disinhibition (HP:0000734) | 2.40461410 |
64 | Gastrointestinal stroma tumor (HP:0100723) | 2.39136334 |
65 | Alkalosis (HP:0001948) | 2.35106167 |
66 | Widely patent fontanelles and sutures (HP:0004492) | 2.32489033 |
67 | Prolonged neonatal jaundice (HP:0006579) | 2.30748716 |
68 | Renal salt wasting (HP:0000127) | 2.28708892 |
69 | Xanthomatosis (HP:0000991) | 2.26571598 |
70 | Loss of speech (HP:0002371) | 2.25616710 |
71 | Metaphyseal cupping (HP:0003021) | 2.21893228 |
72 | Recurrent bronchitis (HP:0002837) | 2.21464245 |
73 | Agnosia (HP:0010524) | 2.18459766 |
74 | Malnutrition (HP:0004395) | 2.18250331 |
75 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.16532748 |
76 | Petechiae (HP:0000967) | 2.16155942 |
77 | Pathologic fracture (HP:0002756) | 2.15313230 |
78 | Hypobetalipoproteinemia (HP:0003563) | 2.14775370 |
79 | Progressive visual loss (HP:0000529) | 2.14496270 |
80 | Steatorrhea (HP:0002570) | 2.13837444 |
81 | Hypophosphatemia (HP:0002148) | 2.13702027 |
82 | Sensorimotor neuropathy (HP:0007141) | 2.13440084 |
83 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.13243790 |
84 | Myocardial infarction (HP:0001658) | 2.12953652 |
85 | Bronchitis (HP:0012387) | 2.11793520 |
86 | Cerebral inclusion bodies (HP:0100314) | 2.10649691 |
87 | Hemorrhage of the eye (HP:0011885) | 2.10532179 |
88 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.09738485 |
89 | Cervical subluxation (HP:0003308) | 2.08702146 |
90 | Bone pain (HP:0002653) | 2.05158823 |
91 | Vascular calcification (HP:0004934) | 2.04469722 |
92 | Chronic sinusitis (HP:0011109) | 2.02869233 |
93 | Hand muscle atrophy (HP:0009130) | 2.02498069 |
94 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.02359076 |
95 | Delayed epiphyseal ossification (HP:0002663) | 2.01130502 |
96 | Nephrolithiasis (HP:0000787) | 2.00127206 |
97 | Thin bony cortex (HP:0002753) | 1.99958223 |
98 | Purpura (HP:0000979) | 1.99640597 |
99 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.98627762 |
100 | Chronic bronchitis (HP:0004469) | 1.97727011 |
101 | Recurrent sinusitis (HP:0011108) | 1.97218650 |
102 | Decreased circulating renin level (HP:0003351) | 1.96751080 |
103 | Colitis (HP:0002583) | 1.96682725 |
104 | Tetraparesis (HP:0002273) | 1.96666525 |
105 | Hyperphosphaturia (HP:0003109) | 1.96498447 |
106 | Nephritis (HP:0000123) | 1.96023129 |
107 | Abdominal distention (HP:0003270) | 1.96008514 |
108 | Ileus (HP:0002595) | 1.95043556 |
109 | Renal tubular acidosis (HP:0001947) | 1.94452957 |
110 | Recurrent fungal infections (HP:0002841) | 1.94245310 |
111 | Hepatosplenomegaly (HP:0001433) | 1.93865875 |
112 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.93752726 |
113 | Polygenic inheritance (HP:0010982) | 1.93108154 |
114 | Mediastinal lymphadenopathy (HP:0100721) | 1.92491505 |
115 | Peripheral demyelination (HP:0011096) | 1.92421190 |
116 | Flat acetabular roof (HP:0003180) | 1.92182882 |
117 | Protuberant abdomen (HP:0001538) | 1.90712332 |
118 | Esophageal varix (HP:0002040) | 1.90256621 |
119 | Global brain atrophy (HP:0002283) | 1.89234270 |
120 | Amyloidosis (HP:0011034) | 1.89157227 |
121 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.87903236 |
122 | Villous atrophy (HP:0011473) | 1.87903236 |
123 | Bronchiectasis (HP:0002110) | 1.87221380 |
124 | Elevated alkaline phosphatase (HP:0003155) | 1.86329640 |
125 | Premature loss of primary teeth (HP:0006323) | 1.85870505 |
126 | Abnormality of vitamin metabolism (HP:0100508) | 1.85693936 |
127 | Thoracic kyphosis (HP:0002942) | 1.84740102 |
128 | Recurrent skin infections (HP:0001581) | 1.83778666 |
129 | Abnormality of renin-angiotensin system (HP:0000847) | 1.83502230 |
130 | Hyperparathyroidism (HP:0000843) | 1.83368218 |
131 | Personality changes (HP:0000751) | 1.83262530 |
132 | Vasculitis (HP:0002633) | 1.82902878 |
133 | Irritability (HP:0000737) | 1.82108004 |
134 | Emphysema (HP:0002097) | 1.81508990 |
135 | Orchitis (HP:0100796) | 1.81473685 |
136 | Dementia (HP:0000726) | 1.80836762 |
137 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.80657403 |
138 | Hypotension (HP:0002615) | 1.80505477 |
139 | Nuclear cataract (HP:0100018) | 1.80217162 |
140 | Abnormal drinking behavior (HP:0030082) | 1.79672296 |
141 | Polydipsia (HP:0001959) | 1.79672296 |
142 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.79574171 |
143 | Focal segmental glomerulosclerosis (HP:0000097) | 1.79500590 |
144 | Abnormal urine phosphate concentration (HP:0012599) | 1.79359777 |
145 | Poor head control (HP:0002421) | 1.79170826 |
146 | Neuronal loss in central nervous system (HP:0002529) | 1.78429688 |
147 | Hyperammonemia (HP:0001987) | 1.77554470 |
148 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.77209095 |
149 | Increased serum ferritin (HP:0003281) | 1.74040546 |
150 | Meningitis (HP:0001287) | 1.73356886 |
151 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.70052812 |
152 | Progressive neurologic deterioration (HP:0002344) | 1.69882425 |
Rank | Gene Set | Z-score |
---|---|---|
1 | SMG1 | 3.22569255 |
2 | EPHA2 | 3.07739874 |
3 | BLK | 3.06001688 |
4 | PBK | 2.96114989 |
5 | IRAK3 | 2.94034399 |
6 | ERN1 | 2.85814885 |
7 | WNK4 | 2.72121708 |
8 | ACVR1B | 2.71208411 |
9 | PRPF4B | 2.53164540 |
10 | MST4 | 2.51782427 |
11 | NME2 | 2.47732510 |
12 | TBK1 | 2.40823251 |
13 | TYK2 | 2.29263203 |
14 | MST1R | 2.22765953 |
15 | RIPK4 | 2.17616516 |
16 | MAP3K14 | 2.06078316 |
17 | WNK3 | 1.89660130 |
18 | TRIB3 | 1.88116099 |
19 | NEK1 | 1.87479679 |
20 | MAP4K1 | 1.86503429 |
21 | PIM2 | 1.86492202 |
22 | STK10 | 1.77393512 |
23 | PRKD3 | 1.68327935 |
24 | OXSR1 | 1.67462612 |
25 | EPHB1 | 1.65010654 |
26 | GRK6 | 1.63766524 |
27 | PAK4 | 1.62693307 |
28 | MAP3K3 | 1.60159512 |
29 | LRRK2 | 1.59762001 |
30 | CDC42BPA | 1.53385604 |
31 | MAP3K11 | 1.52111859 |
32 | SCYL2 | 1.47900930 |
33 | GRK7 | 1.46139523 |
34 | TESK2 | 1.42820015 |
35 | ZAP70 | 1.42378331 |
36 | KIT | 1.42271194 |
37 | ABL2 | 1.39864685 |
38 | FGFR4 | 1.34551522 |
39 | BUB1 | 1.32129049 |
40 | TGFBR2 | 1.29906343 |
41 | TESK1 | 1.24869153 |
42 | IRAK4 | 1.22648703 |
43 | NEK9 | 1.19805655 |
44 | MATK | 1.15222656 |
45 | BCKDK | 1.14755793 |
46 | PDK2 | 1.14388723 |
47 | BMX | 1.12183445 |
48 | IKBKB | 1.10378272 |
49 | MAP2K3 | 1.10039421 |
50 | MAP2K2 | 1.09398347 |
51 | RIPK1 | 1.07075603 |
52 | CSK | 1.05599026 |
53 | RPS6KA4 | 1.05165350 |
54 | PTK6 | 1.03787963 |
55 | WEE1 | 1.03682434 |
56 | EIF2AK1 | 1.01008888 |
57 | SIK1 | 1.00497142 |
58 | PIM1 | 0.98516491 |
59 | ICK | 0.97610060 |
60 | MAP3K8 | 0.97214956 |
61 | JAK1 | 0.92142273 |
62 | IKBKE | 0.91481266 |
63 | ARAF | 0.90300203 |
64 | FER | 0.86454239 |
65 | EEF2K | 0.85094288 |
66 | FGFR3 | 0.84293787 |
67 | JAK3 | 0.83899896 |
68 | TNK2 | 0.82730015 |
69 | ALK | 0.78975868 |
70 | PDK3 | 0.76938635 |
71 | PDK4 | 0.76938635 |
72 | MOS | 0.76265789 |
73 | FES | 0.74434273 |
74 | DAPK1 | 0.73788025 |
75 | PDK1 | 0.72864053 |
76 | KDR | 0.72662586 |
77 | STK38L | 0.72329390 |
78 | CSF1R | 0.71814482 |
79 | PKN2 | 0.70862140 |
80 | MET | 0.70367679 |
81 | TAOK2 | 0.67836187 |
82 | PRKCD | 0.67217168 |
83 | MAP2K6 | 0.66929206 |
84 | JAK2 | 0.66305885 |
85 | MARK3 | 0.65751933 |
86 | MAP3K10 | 0.64816611 |
87 | TIE1 | 0.62980698 |
88 | CDK12 | 0.62239602 |
89 | MAP3K13 | 0.61222613 |
90 | CHUK | 0.59765597 |
91 | PAK1 | 0.59382388 |
92 | PRKG2 | 0.59154736 |
93 | MAPKAPK3 | 0.57737757 |
94 | NEK2 | 0.55637909 |
95 | SYK | 0.55077143 |
96 | HCK | 0.54974253 |
97 | PTK2 | 0.54348712 |
98 | FGR | 0.53865086 |
99 | MAP3K5 | 0.52224436 |
100 | IRAK2 | 0.51719961 |
101 | GSK3A | 0.51180619 |
102 | IRAK1 | 0.49982410 |
103 | EGFR | 0.49164367 |
104 | SIK3 | 0.49137911 |
105 | LYN | 0.48885702 |
106 | MAPK11 | 0.48585592 |
107 | STK4 | 0.48023076 |
108 | MAPK15 | 0.47908828 |
109 | RPS6KA2 | 0.47760282 |
110 | LMTK2 | 0.46600375 |
111 | PDPK1 | 0.46473375 |
112 | LCK | 0.46242497 |
113 | PRKCI | 0.45807054 |
114 | MAP3K9 | 0.44319018 |
115 | TTK | 0.44267348 |
116 | CDK6 | 0.44053774 |
117 | SRC | 0.43372894 |
118 | STK3 | 0.43192226 |
119 | CAMKK2 | 0.42563354 |
120 | PIK3CG | 0.42461599 |
121 | KSR2 | 0.41639384 |
122 | BMPR2 | 0.41406032 |
123 | PRKD2 | 0.40428939 |
124 | DAPK3 | 0.39702280 |
125 | GRK5 | 0.39213254 |
126 | BTK | 0.38917177 |
127 | DAPK2 | 0.38518252 |
128 | DDR2 | 0.37153282 |
129 | NEK6 | 0.36477383 |
130 | FYN | 0.35562380 |
131 | TTN | 0.35481943 |
132 | MARK2 | 0.34432098 |
133 | ABL1 | 0.34424474 |
134 | CAMK1D | 0.34339043 |
135 | TAOK1 | 0.33326226 |
136 | MAP3K1 | 0.32664035 |
137 | EPHA3 | 0.29317850 |
138 | CDK4 | 0.29313009 |
139 | MAPKAPK2 | 0.29141181 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Lysosome_Homo sapiens_hsa04142 | 3.06468365 |
2 | Other glycan degradation_Homo sapiens_hsa00511 | 2.98539512 |
3 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.52306394 |
4 | Mineral absorption_Homo sapiens_hsa04978 | 2.38603723 |
5 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.33073129 |
6 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.32534028 |
7 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.23348124 |
8 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.22783124 |
9 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.22456159 |
10 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.11293733 |
11 | * Histidine metabolism_Homo sapiens_hsa00340 | 2.05112783 |
12 | Renin-angiotensin system_Homo sapiens_hsa04614 | 2.03672387 |
13 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.03664503 |
14 | Allograft rejection_Homo sapiens_hsa05330 | 2.00127340 |
15 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.85455830 |
16 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.84084765 |
17 | Leishmaniasis_Homo sapiens_hsa05140 | 1.74134050 |
18 | Legionellosis_Homo sapiens_hsa05134 | 1.72738147 |
19 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.71240605 |
20 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.66581944 |
21 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.61405111 |
22 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.59940274 |
23 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.56298800 |
24 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.50795529 |
25 | Tuberculosis_Homo sapiens_hsa05152 | 1.50415003 |
26 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.49601918 |
27 | Proteasome_Homo sapiens_hsa03050 | 1.48790272 |
28 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.47105642 |
29 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.46954308 |
30 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.45683417 |
31 | Phagosome_Homo sapiens_hsa04145 | 1.45342869 |
32 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.44327678 |
33 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.43010326 |
34 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.42107444 |
35 | Retinol metabolism_Homo sapiens_hsa00830 | 1.36112781 |
36 | Peroxisome_Homo sapiens_hsa04146 | 1.32024176 |
37 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.29393235 |
38 | Carbon metabolism_Homo sapiens_hsa01200 | 1.29323927 |
39 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.26747688 |
40 | Pertussis_Homo sapiens_hsa05133 | 1.26620627 |
41 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.26301214 |
42 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.24537495 |
43 | Galactose metabolism_Homo sapiens_hsa00052 | 1.19105828 |
44 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.18021350 |
45 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.16566883 |
46 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.15989441 |
47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.15677552 |
48 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.10396532 |
49 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.10017560 |
50 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.07592114 |
51 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.07168217 |
52 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.05303982 |
53 | Salmonella infection_Homo sapiens_hsa05132 | 1.02330500 |
54 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.01395724 |
55 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.00384450 |
56 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.98622371 |
57 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.95395024 |
58 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.94813898 |
59 | Shigellosis_Homo sapiens_hsa05131 | 0.94545901 |
60 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.94259484 |
61 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.93110895 |
62 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.93020487 |
63 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.90868009 |
64 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.90380182 |
65 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.89204748 |
66 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.89163258 |
67 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.88621046 |
68 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.86598812 |
69 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.85519858 |
70 | Apoptosis_Homo sapiens_hsa04210 | 0.83764425 |
71 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.83183633 |
72 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.82884873 |
73 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.80517412 |
74 | Viral myocarditis_Homo sapiens_hsa05416 | 0.80068308 |
75 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.79950075 |
76 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.79324381 |
77 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.78822883 |
78 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.78404259 |
79 | Bile secretion_Homo sapiens_hsa04976 | 0.78032350 |
80 | Influenza A_Homo sapiens_hsa05164 | 0.76400604 |
81 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.74898099 |
82 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.73816843 |
83 | Malaria_Homo sapiens_hsa05144 | 0.72674915 |
84 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.71261958 |
85 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.69771496 |
86 | Prion diseases_Homo sapiens_hsa05020 | 0.68912811 |
87 | * Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.67736412 |
88 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.66165477 |
89 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.66157244 |
90 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.65827530 |
91 | Measles_Homo sapiens_hsa05162 | 0.65717053 |
92 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.64571360 |
93 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.64088901 |
94 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.63823407 |
95 | Hepatitis C_Homo sapiens_hsa05160 | 0.63102609 |
96 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.63038761 |
97 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.62186304 |
98 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.60828299 |
99 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.60606308 |
100 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.59747434 |
101 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.59664610 |
102 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.58179587 |
103 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.57238630 |
104 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.56015080 |
105 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.55731913 |
106 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.54672575 |
107 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.54083936 |
108 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.54059390 |
109 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.53313228 |
110 | * beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.52798290 |
111 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.52689116 |
112 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.50750466 |
113 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.49217287 |
114 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.49139029 |
115 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.44598364 |
116 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.44222686 |
117 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.43858294 |
118 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.42312871 |
119 | Amoebiasis_Homo sapiens_hsa05146 | 0.42286263 |
120 | ABC transporters_Homo sapiens_hsa02010 | 0.39941125 |
121 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.39920067 |
122 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.38464253 |
123 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.37411404 |
124 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.36702136 |
125 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.36105045 |
126 | Asthma_Homo sapiens_hsa05310 | 0.35095150 |
127 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.31100807 |
128 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.30780422 |